SAB Biotherapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Miami Beach, FL
SABS chart
What traders are saying about $SABS
Latest postsSAB Biotherapeutics, Inc. news
- Three talks will feature SAB Biotherapeutics' CEO in London and Florida.
Stock Titan ·
- SAB Biotherapeutics, Inc. (SABS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- What SAB Biotherapeutics (SABS) Said on Its Q3 Earnings Call
marketbeat.com ·
- SAB Biotherapeutics (SABS) Q3 2026 Earnings Call Transcript
fool.com ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- SAB Biotherapeutics Inc (SABS) (Q3 2026) Earnings Call Highlights: FDA Fast-Track Win, Full ...
Yahoo Finance ·
- SAB Biotherapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- SAB Biotherapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
- SAB Biotherapeutics 3Q 2026: EPS ($0.24) — 10-Q Summary
TradingView ·
- A year-earlier $45.4M profit turns to a Q3 loss at SAB Biotherapeutics (SABS).
Stock Titan ·
- SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
Yahoo Finance ·
- SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
Yahoo Finance ·
SAB Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $1.3M | $2.2M | $23.9M |
| Net income | $13.3M | -$34.1M | -$42.2M | -$18.7M |
| Diluted EPS | $-0.79 | $-3.68 | $-7.64 | $-4.31 |
| Total assets (year end) | $172.8M | $44.2M | $83.9M | $50.9M |
| Cash and equivalents (year end) | $10.5M | $8.9M | $56.6M | $15.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About SAB Biotherapeutics, Inc.
- Ticker
- SABS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Miami Beach, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1833214
- Former names
- Big Cypress Acquisition Corp.
Frequently asked questions
What exchange is SAB Biotherapeutics, Inc. listed on?
SAB Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol SABS.
What industry is SAB Biotherapeutics, Inc. in?
SAB Biotherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is SAB Biotherapeutics, Inc. headquartered?
SAB Biotherapeutics, Inc.'s business address on file with the SEC is in Miami Beach, FL.
When does SAB Biotherapeutics, Inc.'s fiscal year end?
SAB Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did SAB Biotherapeutics, Inc. report?
SAB Biotherapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.